🔆 📖 👤

Statutory Instruments

2007 No. 803

fees and charges

medicines

consumer protection

The Medicines for Human Use and Medical Devices (Fees Amendments) (No.2) Regulations 2007

Made

12th March 2007

Laid before Parliament

16th March 2007

Coming into force

for the purpose of regulation 14

13th March 2007

for all other purposes

1st April 2007

The Secretary of State for Health, the Department of Health, Social Services and Public Safety and the Department of Agriculture and Rural Development, acting jointly, make the following Regulations in exercise of the powers conferred on them by section 1(1) and (2) of the Medicines Act 1971 or, as the case may be, the powers conferred by those provisions and now vested in them .

In so far as these Regulations are not made under section 1(1) and (2) of the Medicines Act 1971, the Secretary of State makes these Regulations in exercise of the powers conferred on her by section 2(2) of the European Communities Act 1972 and section 56(1) and (2) of the Finance Act 1973. The Secretary of State has been designated for the purposes of section 2(2) of the European Communities Act 1972 in relation to medicinal products and medical devices .

The Treasury has consented to the making of these Regulations as required by section 1(1) of the Medicines Act 1971 and section 56(1) of the Finance Act 1973.

In accordance with section 129(6) of the Medicines Act 1968 , the Secretary of State for Health, the Department of Health, Social Services and Public Safety Development and the Department of Agriculture and Rural Development have consulted with such organisations as appear to them to be representative of interests likely to be substantially affected by these Regulations.

Citation, commencement and interpretation

1. —(1) These Regulations may be cited as the Medicines for Human Use and Medical Devices (Fees Amendments) (No.2) Regulations 2007 and shall come into force—

(a) for the purposes of regulation 14, on 13th March 2007; and

(b) for all other purposes, on 1st April 2007.

(2) In these Regulations, “ the Medicines Fees Regulations ” means the Medicines (Products for Human Use—Fees) Regulations 1995 .

Amendment of the Medicines (Homoeopathic Medicinal Products for Human Use) Regulations 1994

2. —(1)The Medicines (Homoeopathic Medicinal Products for Human Use) Regulations 1994 are amended as follows.

(2) In regulation 14 (fees for variations of certificates)

(a) in paragraph (2)(a), for “£226” substitute “£237”;

(b) in paragraph (2)(b)(i), for “£226” substitute “£237”;

(c) in paragraph (2)(b)(ii), for “£226” substitute “£237”;

(d) in paragraph (2)(b)(iii), for “£114” substitute “£120”; and

(e) in paragraph (2)(b)(iv), for “£57” substitute “£60”.

(3) In regulation 15 (fees payable by holders of certificates), in paragraph (1), for “£15” substitute “ £19 ” .

(4) In the table in Schedule 2 (fees for applications for the grant of certificates of registration)

(a) in column (2) (fees for applications in respect of products prepared from not more than 5 homoeopathic stocks)—

(i) for “£148” substitute “ £155 ” ,

(ii) for “£444” substitute “ £466 ” ,

(iii) in paragraph 3, for “£465” substitute “ £488 ” , and

(iv) for “£734” substitute “ £770 ” ; and

(b) in column (3) (fees for other applications)—

(i) for “£365” substitute “ £383 ” ,

(ii) for “£654” substitute “ £686 ” ,

(iii) in paragraph 3, for “£608” substitute “ £622 ” , and

(iv) for “£960” substitute “ £1,007 ” .

(5) In Schedule 2A (fees for assistance in obtaining certificates of registration in other EEA States) , in paragraph 2—

(a) in sub-paragraph (a), for “£266” substitute “ £279 ” ; and

(b) in sub-paragraph (b), for “£348” substitute “£365”.

Amendment of Part I of the Medicines Fees Regulations

3. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Amendment of Part IA of the Medicines Fees Regulations

4. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Amendment of Part VI of the Medicines Fees Regulations

5. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Amendment of Part VII of the Medicines Fees Regulations

6. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Amendment of Schedule 1 to the Medicines Fees Regulations

7. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Amendment of Schedule 2 to the Medicines Fees Regulations

8. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Amendment of Schedule 3 to the Medicines Fees Regulations

9. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Amendment of Schedule 6 to the Medicines Fees Regulations

10. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Increase in fee amounts prescribed by the Medicines Fees Regulations

11. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Amendment of the Medical Devices (Consultation Requirements) (Fees) Regulations 1995

12. —(1)The Medical Devices (Consultation Requirements) (Fees) Regulations 1995 are amended as follows.

(2) In regulation 1 (citation, commencement and interpretation), in paragraph (2)—

(a) for the definitions of “Annex II” and “Annex III” substitute the following definitions—

“Annex I”, “Annex II” and “Annex III” mean respectively Annex I, Annex II and Annex III to the Directive; ;

(b) in the definition of “competent body”, for the words from “Directive “ the 2001 Directive ” ;

(c) after the definition of “the Directive” insert the following definition—

the 2001 Directive ” means Directive 2001/83/EC of the European Parliament and of the Council on the Community code relating to medicinal products for human use, as amended by—

(a)

Directive 2002/98/EC of the European Parliament and of the Council setting standards of quality and safety for the collection, testing, processing, storage and distribution of human blood and blood components,

(b)

Commission Directive 2003/63/EC amending Directive 2001/83/EC ,

(c)

Directive 2004/24/EC of the European Parliament and of the Council amending, as regards traditional herbal medicinal products, Directive 2001/83/EC ,

(d)

Directive 2004/27/EC of the European Parliament and of the Council also amending Directive 2001/83/EC , and

(e)

Regulation (EC) No. 1901/2006 of the European Parliament and of the Council on medicinal products for paediatric use and amending Regulation (EEC) No 1768/92, Directive 2001/20/EC , Directive 2001/83/EC and Regulation (EC) No 726/2004 ; ;

(d) omit the definition of “fee”;

(e) in the definition of “manufacturing authorisation”, for the words from “Directive “ the 2001 Directive ” ; and

(f) in the definition of “medicinal substance”, for the words from “Directive “ the 2001 Directive ” .

(3) In regulation 2 (circumstances in which a fee is payable), in paragraph (1), after “pay a fee” insert “ specified by, or determined under, regulation 3 ” .

(4) In regulation 3 (fees)—

(a) in paragraph (1)—

(i) in sub-paragraph (a), for “£3,948” substitute “£4,141”, and

(ii) in sub-paragraph (b), for “£9,202” substitute “£9,653”;

(b) in paragraph (2)—

(i) in sub-paragraph (a), for “£781” substitute “ £819 ” , and

(ii) in sub-paragraph (b), for “£2,184” substitute “£2,291”;

(c) in paragraph (3)—

(i) in sub-paragraph (a), for “£3,948” substitute “£4,141”, and

(ii) in sub-paragraph (b), for “£9,262” substitute “£9,653”;

(d) in paragraph (4)—

(i) in sub-paragraph (a), for “£781” substitute “ £819 ” , and

(ii) in sub-paragraph (b), for “£2,184” substitute “£2,291”; and

(e) in paragraph (5)—

(i) in sub-paragraph (a), for “£40,374” substitute “£42,352”, and

(ii) in sub-paragraph (b), for “£10,024” substitute “£10,515”.

(5) After regulation 3 insert the following regulation—

Fees for pre-consultation meetings

3A. —(1) Where the Department of Health holds a meeting—

(a) with a person other than a notified body for the purpose of providing scientific advice to that person with a view to him making an application for an EC examination certificate in relation to a medical device incorporating a medicinal substance, or

(b) with a notified body for the purpose of providing scientific advice to that body with a view to that body consulting the Department in relation to an application for an EC examination certificate in relation to a medical device incorporating a medicinal substance,

that person or notified body shall pay the fee specified in paragraph (2).

(2) The fee payable shall be—

(a) if the advice provided at that meeting consists of advice in connection with—

(i) quality development only, or

(i) safety development only,

£750;

(b) if the advice provided at that meeting consists of advice in connection with—

(i) quality and safety development only, or

(i) clinical development only,

£950;

(c) if the advice provided at that meeting consists of advice in connection with—

(i) quality and clinical development only, or

(i) safety and clinical development only,

£1,300;

(a) if the advice provided at that meeting consists of advice in connection with quality, safety and clinical development, £1,650.

(3) In this regulation—

clinical development ” means the conduct of studies of a medicinal substance in human subjects in order to—

(a)

discover or verify the effects of such a substance,

(b)

identify any adverse reaction to such a substance, or

(c)

study absorption, distribution, metabolism and excretion of such a substance,

with the object of ascertaining the safety or efficacy of that substance, as required to verify the safety and usefulness of the substance in accordance with paragraph 7.4 of Annex I;

quality development ” means the chemical, pharmaceutical and biological testing required in order to verify the quality of a medicinal substance in accordance with paragraph 7.4 of Annex I;

safety development ” means the toxicological and pharmacological testing required in order to verify the safety of a medicinal substance in accordance with paragraph 7.4 of Annex I; and

scientific advice ” means advice in connection with the quality, safety or clinical development for a medicinal substance incorporated, or to be incorporated, in a medical device. .

(6) For regulation 4 (payment and recovery of fees) substitute the following regulation—

Payment and recovery of fees

4. —(1) Any fee payable in accordance with regulations 2 and 3 shall be paid to the Secretary of State not later than the day on which a notified body consults the competent body.

(2) Any fee payable in accordance with regulation 3A shall become payable within 14 days following written notice from the Department of Health requiring payment of that fee.

(3) All unpaid sums due on account of any fee payable under these Regulations shall be recoverable as debts due to the Crown. .

Amendment of the Medical Devices Regulations 2002

13. —(1)The Medical Devices Regulations 2002 shall be amended as follows.

(2) In regulation 54 (fees payable in connection with the designation etc of UK notified bodies)

(a) in paragraph (1)—

(i) in sub-paragraph (a), for “£650” substitute “ £850 ” , and

(ii) in sub-paragraph (b), for “£2,600” substitute “£3,400”;

(b) in paragraph (2), for “£1,300” substitute “£1,700”;

(c) in paragraph (3), for sub-paragraphs (a) to (c) substitute the following sub-paragraphs—

(a) in respect of an initial inspection pursuant to regulation 45(7)(a), a fee of £4,200 plus the amounts specified in paragraph (3A);

(b) in respect of an inspection pursuant to regulation 45(7)(a), other than an initial inspection—

(i) if the inspection is for the purposes of deciding whether or not the body is one in respect of which the criteria set out in all three of the Annexes referred to in this paragraph are met, a fee of £6,800,

(ii) if the inspection is for the purpose of deciding whether or not the body is one in respect of which the criteria set out in only two of the three Annexes referred to in this paragraph are met, a fee of £5,100, or

(iii) if the inspection is for the purposes of deciding whether or not the body is one in respect of which the criteria set out in only one of the Annexes referred to in this paragraph are met, or for the purposes of deciding whether or not a body is capable of fulfilling the functions of an importing Party arising out of the Mutual Recognition Agreements which it needs to be able to fulfil, a fee of £3,400,

plus the amounts specified in paragraph (3A); and

(c) in respect of an inspection pursuant to regulation 45(7)(b), a fee of £3,400 plus the amounts specified in paragraph (3A). ; and

(d) after paragraph (3), insert the following paragraphs—

(3A) Subject to paragraph (3B), the additional amounts payable in respect of an inspection referred to in paragraph (3) shall be—

(a) an amount for time spent by a member of staff undertaking a site visit at a rate—

(i) for the time spent on site, of £240 per half day (periods of less than a half day counting as a half day) up to a maximum of two half days on any one date, and

(ii) for the time spent travelling to and from the site, of £67.10 per hour;

(b) the actual costs of travel, accommodation and subsistence; and

(c) out of pocket expenses.

(3B) Where the Secretary of State conducts an inspection referred to in paragraph (3)(a) on the same date and at the same premises as an inspection pursuant to regulation 48(7)(a)—

(a) the amount referred to in paragraph (3A)(3) shall include an amount for any time spent on site by a member of staff which is attributable to the conduct of the inspection pursuant to regulation 48(7)(a), at the rate referred to paragraph (3A)(a)(i); and

(b) the costs and expenses referred to in paragraph (3A)(b) and (c) shall include any additional costs and expenses attributable to the conduct of the inspection pursuant to regulation 48(7)(a). .

(3) In regulation 55 (fees payable in connection with the designation etc of EC conformity assessment bodies)

(a) in paragraph (1)—

(i) in sub-paragraph (a), for “£650” substitute “ £850 ” , and

(ii) in sub-paragraph (b), for “£2,600” substitute “£3,400”;

(b) in paragraph (2), for “£1,300” substitute “£1,700”;

(c) in paragraph (3)—

(i) at the beginning insert “ Subject to paragraphs (3A) to (3C) ” , and

(ii) for paragraphs (a) to (c) substitute the following sub-paragraphs—

(a) in respect of an initial inspection pursuant to regulation 48(7)(a), other than an inspection referred to in sub-paragraph (c), fee of £4,200 plus the amounts specified in paragraph (3D);

(b) in respect of any other inspection pursuant to regulation 48(7)(a), other than an inspection referred to in sub-paragraph (c), a fee of £3,400 plus the amounts specified in paragraph (3D);

(c) in respect of an inspection pursuant to regulation 48(7)(a) conducted on the same date and at the same premises as an inspection pursuant to regulation 45(7), a fee of £1,700;

(d) in respect of an inspection pursuant to regulation 48(7)(b), a fee of £3,400 plus the amounts specified in paragraph (3D). ; and

(d) after paragraph (3), insert the following paragraphs—

(3A) Where the Secretary of State conducts two or more inspections pursuant to regulation 48(7)(a) on the same date and at the same premises, other than inspections referred to in paragraph (3)(c), and one of the inspections is an initial inspection, the fee payable shall be £4,200 plus—

(a) £1,700 for each additional inspection; and

(b) the amounts specified in paragraph (3D).

(3B) Where the Secretary of State conducts two or more inspections pursuant to regulation 48(7)(a) on the same date and at the same premises, other than inspections referred to in paragraph (3)(c), and none of the inspections is an initial inspection, the fee payable shall be £3,400 plus—

(a) £1,700 for each additional inspection; and

(b) the amounts specified in paragraph (3D)

(3C) Where the Secretary of State conducts two or more inspections referred to in paragraph (3)(c) on the same date and at the same premises, the fee payable for the inspections pursuant to regulation 48(7)(a) shall be £1,700 for each inspection.

(3D) The additional amounts payable in respect of an inspection referred to in paragraphs (3) to (3B) shall be—

(a) an amount for time spent by a member of staff undertaking a site visit at a rate—

(i) for the time spent on site, of £240 per half day (periods of less than a half day counting as a half day) up to a maximum of two half days on any one date, and

(ii) for the time spent travelling to and from the site, of £67.10 per hour;

(b) the actual costs of travel, accommodation and subsistence, and

(c) out of pocket expenses. .

(4) In regulation 56 (fees payable in relation to clinical investigations), in paragraph (1)—

(a) in sub-paragraph (a)—

(i) in sub-paragraph (i), for “£1,600” substitute “£1,800”, and

(ii) in sub-paragraph (ii), for “£2,100” substitute “£2,400”; and

(b) in sub-paragraph (b)—

(i) in sub-paragraph (i), for “£2,200” substitute “£2,700”, and

(ii) in sub-paragraph (ii), for “£3,000” substitute “£3,800”.

Revocation of regulations

14.The Medicines for Human Use and Medical Devices (Fees Amendments) Regulations 2007 are hereby revoked.

Signed by authority of the Secretary of State

Hunt

Minister of State

Department of Health

Sealed with the Official Seal of the Department of Health, Social Services and Public Safety

L.S.

Andrew McCormick

Permanent Secretary

Department of Health, Social Services and Public Safety

Sealed with the Official Seal of the Department of Agriculture and Rural Development

L.S.

Pat Toal

Permanent Secretary

Department of Agriculture and Rural Development

We consent,

Dave Watts

Frank Roy

Two of the Lords Commissioners of Her Majesty's Treasury

Regulation 11

SCHEDULE

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Status: There are currently no known outstanding effects for the The Medicines for Human Use and Medical Devices (Fees Amendments) (No.2) Regulations 2007.
The Medicines for Human Use and Medical Devices (Fees Amendments) (No.2) Regulations 2007 (2007/803)

Displaying information

Status of this instrument

footnotecommentarytransitional and savingsin force statusrelated provisionsgeo extentinsert/omitsource countin force adj
F1Regs. 3-11 revoked (1.4.2008) by The Medicines (Products for Human Use-Fees) Regulations 2008 (S.I. 2008/552) , regs. 1 , 48(1) , Sch. 7 (with reg. 48(2) )this amendment (text ) should be read in conjunction with other related provisions, see the commentary.
F1Regs. 3-11 revoked (1.4.2008) by The Medicines (Products for Human Use-Fees) Regulations 2008 (S.I. 2008/552) , regs. 1 , 48(1) , Sch. 7 (with reg. 48(2) )this amendment (text ) should be read in conjunction with other related provisions, see the commentary.
F1Regs. 3-11 revoked (1.4.2008) by The Medicines (Products for Human Use-Fees) Regulations 2008 (S.I. 2008/552) , regs. 1 , 48(1) , Sch. 7 (with reg. 48(2) )this amendment (text ) should be read in conjunction with other related provisions, see the commentary.
F1Regs. 3-11 revoked (1.4.2008) by The Medicines (Products for Human Use-Fees) Regulations 2008 (S.I. 2008/552) , regs. 1 , 48(1) , Sch. 7 (with reg. 48(2) )this amendment (text ) should be read in conjunction with other related provisions, see the commentary.
F1Regs. 3-11 revoked (1.4.2008) by The Medicines (Products for Human Use-Fees) Regulations 2008 (S.I. 2008/552) , regs. 1 , 48(1) , Sch. 7 (with reg. 48(2) )this amendment (text ) should be read in conjunction with other related provisions, see the commentary.
F1Regs. 3-11 revoked (1.4.2008) by The Medicines (Products for Human Use-Fees) Regulations 2008 (S.I. 2008/552) , regs. 1 , 48(1) , Sch. 7 (with reg. 48(2) )this amendment (text ) should be read in conjunction with other related provisions, see the commentary.
F1Regs. 3-11 revoked (1.4.2008) by The Medicines (Products for Human Use-Fees) Regulations 2008 (S.I. 2008/552) , regs. 1 , 48(1) , Sch. 7 (with reg. 48(2) )this amendment (text ) should be read in conjunction with other related provisions, see the commentary.
F1Regs. 3-11 revoked (1.4.2008) by The Medicines (Products for Human Use-Fees) Regulations 2008 (S.I. 2008/552) , regs. 1 , 48(1) , Sch. 7 (with reg. 48(2) )this amendment (text ) should be read in conjunction with other related provisions, see the commentary.
F1Regs. 3-11 revoked (1.4.2008) by The Medicines (Products for Human Use-Fees) Regulations 2008 (S.I. 2008/552) , regs. 1 , 48(1) , Sch. 7 (with reg. 48(2) )this amendment (text ) should be read in conjunction with other related provisions, see the commentary.
F2Sch. revoked (1.4.2008) by The Medicines (Products for Human Use-Fees) Regulations 2008 (S.I. 2008/552) , regs. 1 , 48(1) , Sch. 7 (with reg. 48(2) )this amendment (text ) should be read in conjunction with other related provisions, see the commentary.
M11971 c.69 ; as amended by section 21 of the Health and Medicines Act 1988 (c.49) . By virtue of section 1(3) of the 1971 Act, expressions used in that section have the same meaning as in the Medicines Act 1968 (c.67) as amended by S.I. 1969/388 ; see therefore section 1(1) of the 1968 Act, as amended by Schedule 1 to S.I. 1969/388 , which contains a definition of “the Ministers” which is relevant to the powers being exercised in the making of these Regulations. See also regulation 9(12) of the Medicines for Human Use (Marketing Authorisations Etc.) Regulations 1994 (S.I. 1994/3144) , by virtue of which the references in section 1(1) and (2)(b) of the 1971 Act to a licence under Part II of the 1968 Act include reference to a marketing authorization under the 1994 Regulations.
M2In the case of the Secretary of State, by virtue of article 2(1) of S.I. 1999/3142 and article 3(1)(c) and (7) of S.I. 2002/794 . In the case of the Department of Health, Social Services and Public Safety and the Department of Agriculture and Rural Development, by virtue of the powers vested in the Ministers in charge of those Departments by virtue of section 95(5) of, and paragraph 10 of Schedule 12 to, the Northern Ireland Act 1998 (c.47) , which may now be exercised by the Department by virtue of section 1(8) of, and paragraph 4(1)(b) of the Schedule to, the Northern Ireland Act 2000 (c.1) ; the Departments were renamed by virtue of Article 3(4) and (6) of S.I. 1999/283 (N.I. 1) .
M31972 c.68 .
M41973 c.51 .
M5S.I. 1972/181 .
M6The Secretary of State was designated in relation to measures relating to active implantable medical devices in S.I. 1991/2289 , and in relation to measures relating to medical devices other than active implantable medical devices in S.I. 1993/2661 .
M71968 c.67 ; section 129(6) was extended by section 1(3)(b) of the Medicines Act 1971.
M14S.I. 2007/610
Defined TermSection/ArticleIDScope of Application
the Medicines Fees Regulationsreg. 1.legTermp5Yrt6XK

Status of changes to instrument text

The list includes made instruments, both those in force and those yet to come into force. Typically, instruments that are not yet in force (hence their changes are not incorporated into the text above) are indicated by description 'not yet' in the changes made column.